In 12-18% of adult patients, treatment with benznidazole for chronic Chagas disease has to be discontinued because of side-effects. We identified and analysed a cohort of 81 adult patients with three positive tests for Trypanosoma cruzi infection and serological monitoring following incomplete treatment with benznidazole for a median of 10 days. Twenty percent of these patients (16/81) met the criteria of cure, showing that the optimal schedule of benznidazole administration remains to be determined.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.trstmh.2012.07.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!